Susquehanna International Group’s Acrivon Therapeutics ACRV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$52.2K	Buy	43,860 +29,280	+201%	+$34.8K	﹤0.01%	6018
2025 Q1	$29.6K	Buy	+14,580	New	+$29.6K	﹤0.01%	6105
2023 Q2	–	Sell	-32,262	Closed	-$409K	–	5598
2023 Q1	$409K	Buy	+32,262	New	+$409K	﹤0.01%	4072